Financial Ratios Parker-Hannifin Corporation

Stocks

PH

US7010941042

Industrial Machinery & Equipment

Market Closed - NYSE Other stock markets 21:00:02 11/06/2026 BST			5-day change	1st Jan Change
902.37 ^USD	+3.06%		+3.46%	+2.66%

06-10	Bernstein Initiates Parker-Hannifin at Outperform With $1,026 Price Target	MT
05-26	Wells Fargo Adjusts PT on Parker-Hannifin to $950 From $980, Maintains Overweight Rating	MT

e7a4f4f9cfe8f76c22a547536f5fa67.foebWgcafDfE4Yk28pnWfFjVOcflds9V2ipllFqI-VY.RuHJOEZOEX6I0eRMxcuBMCuRbLOrHp0Slxo09x_FiBtKvvERKjcUZaav4g

Published financial data: PARKER-HANNIFIN CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	14.35B	15.86B	19.07B	19.93B	19.85B
Total Revenues	14.35B	15.86B	19.07B	19.93B	19.85B
Cost of Goods Sold, Total	10.41B	11.38B	12.5B	12.77B	12.5B
Gross Profit	3.93B	4.48B	6.57B	7.16B	7.35B
Selling General & Admin Expenses, Total	1.55B	1.58B	3.08B	3.19B	3.14B
Other Operating Expenses, Total	1.55B	1.58B	3.08B	3.19B	3.14B
Operating Income	2.38B	2.91B	3.49B	3.97B	4.21B
Interest Expense, Total	-250M	-255M	-574M	-506M	-409M
Interest And Investment Income	7M	-	46M	15M	11M
Net Interest Expenses	-243M	-255M	-528M	-491M	-398M
Income (Loss) On Equity Invest.	41M	76M	124M	152M	178M
Currency Exchange Gains (Loss)	-	-	-46M	38M	-46M
Other Non Operating Income (Expenses)	18M	18.13M	14.83M	-1.11M	-3M
EBT, Excl. Unusual Items	2.2B	2.75B	3.06B	3.67B	3.94B
Restructuring Charges	-46.64M	-14.75M	-26.71M	-50.39M	-54M
Merger & Related Restructuring Charges	-11.36M	-1.12B	-711M	-38.61M	-44M
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	109M	-879K	363M	11.6M	273M
Other Unusual Items	-	-	-	-	-8M
EBT, Incl. Unusual Items	2.25B	1.61B	2.68B	3.59B	4.11B
Income Tax Expense	500M	298M	596M	750M	575M
Earnings From Continuing Operations	1.75B	1.32B	2.08B	2.84B	3.53B
Net Income to Company	1.75B	1.32B	2.08B	2.84B	3.53B
Minority Interest	-761K	-581K	-600K	-721K	-1M
Net Income - (IS)	1.75B	1.32B	2.08B	2.84B	3.53B
Net Income to Common Incl Extra Items	1.75B	1.32B	2.08B	2.84B	3.53B
Net Income to Common Excl. Extra Items	1.75B	1.32B	2.08B	2.84B	3.53B
Per Share Items
Net EPS - Basic	13.54	10.24	16.23	22.13	27.52
Basic EPS - Continuing Operations	13.54	10.24	16.23	22.13	27.52
Basic Weighted Average Shares Outstanding	129M	129M	128M	129M	128M
Net EPS - Diluted	13.35	10.09	16.04	21.84	27.12
Diluted EPS - Continuing Operations	13.35	10.09	16.04	21.84	27.12
Diluted Weighted Average Shares Outstanding	131M	130M	130M	130M	130M
Normalized Basic EPS	10.63	13.34	14.87	17.85	19.19
Normalized Diluted EPS	10.48	13.16	14.7	17.62	18.91
Dividend Per Share	3.67	4.42	5.47	6.07	6.69
Payout Ratio	27.18	43.27	33.76	27.46	24.38
Supplemental Items
EBITDA	2.98B	3.48B	4.31B	4.9B	5.12B
EBITA	2.71B	3.22B	3.99B	4.55B	4.76B
EBIT	2.38B	2.91B	3.49B	3.97B	4.21B
EBITDAR	3.04B	3.54B	4.38B	4.98B	5.2B
Effective Tax Rate - (Ratio)	22.26	18.46	22.25	20.86	14
Current Domestic Taxes	282M	346M	207M	362M	505M
Current Foreign Taxes	270M	303M	297M	355M	374M
Total Current Taxes	552M	649M	504M	717M	879M
Deferred Domestic Taxes	-60.35M	-305M	105M	16.5M	-150M
Deferred Foreign Taxes	8.85M	-45.98M	-13.51M	15.98M	-154M
Total Deferred Taxes	-51.5M	-351M	91.86M	32.48M	-304M
Normalized Net Income	1.37B	1.72B	1.91B	2.29B	2.46B
Interest on Long-Term Debt	-	-	4.38M	5.34M	5M
Non-Cash Pension Expense	48.14M	3.76M	-70.05M	-74.41M	-52M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	259M	265M	331M	298M	298M
Net Rental Expense, Total	61.68M	58.92M	73.74M	82.27M	83M
Imputed Operating Lease Interest Expense	16.11M	13.12M	27.6M	28.26M	26.78M
Imputed Operating Lease Depreciation	45.57M	45.79M	46.13M	54.01M	56.22M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	188M	224M	247M	273M	159M
Total Stock-Based Compensation	188M	224M	247M	273M	159M

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	733M	536M	475M	422M	467M
Short Term Investments	39.12M	27.86M	8.39M	-	-
Total Cash And Short Term Investments	772M	564M	484M	422M	467M
Accounts Receivable, Total	2.22B	2.37B	2.95B	3B	3.06B
Other Receivables	176M	169M	207M	238M	234M
Notes Receivable	144M	104M	102M	93.11M	84M
Total Receivables	2.54B	2.64B	3.26B	3.33B	3.38B
Inventory	2.09B	2.21B	2.91B	2.79B	2.84B
Prepaid Expenses	210M	243M	183M	256M	263M
Restricted Cash	-	6.11B	-	-	-
Other Current Assets, Total	5.49M	271M	-	-	4M
Total Current Assets	5.62B	12.05B	6.83B	6.8B	6.95B
Gross Property Plant And Equipment	6.17B	6.03B	7.1B	7.3B	7.61B
Accumulated Depreciation	-3.77B	-3.78B	-4B	-4.2B	-4.48B
Net Property Plant And Equipment	2.4B	2.26B	3.1B	3.1B	3.13B
Long-term Investments	640M	632M	827M	944M	280M
Goodwill	8.06B	7.74B	10.63B	10.51B	10.69B
Other Intangibles, Total	3.52B	3.14B	8.45B	7.82B	7.37B
Accounts Receivable Long-Term	1.88M	794K	23.71M	21.06M	16M
Deferred Tax Assets Long-Term	104M	111M	81.43M	92.7M	270M
Other Long-Term Assets, Total	-	21.44M	21.58M	16.32M	781M
Total Assets	20.34B	25.94B	29.96B	29.3B	29.49B
Liabilities
Accounts Payable, Total	1.67B	1.73B	2.05B	1.99B	2.13B
Accrued Expenses, Total	1.09B	1.03B	1.25B	1.33B	1.22B
Short-term Borrowings	5K	1.42B	1.79B	2.14B	1.78B
Current Portion of Long-Term Debt	2.82M	302M	1.97B	1.25B	1M
Current Portion of Leases	40.19M	36.02M	54.72M	59.2M	53M
Current Income Taxes Payable	236M	250M	375M	355M	382M
Unearned Revenue Current, Total	51.21M	60.47M	245M	184M	211M
Other Current Liabilities	10.34M	1.02B	-	72K	38M
Total Current Liabilities	3.1B	5.86B	7.74B	7.31B	5.82B
Long-Term Debt	6.58B	9.76B	8.8B	7.06B	7.39B
Long-Term Leases	93.9M	100M	288M	278M	256M
Unearned Revenue Non Current	3.08M	2.22M	78.24M	77.96M	71M
Pension & Other Post Retirement Benefits	1.06B	640M	552M	437M	267M
Deferred Tax Liability Non Current	554M	307M	1.65B	1.58B	1.49B
Other Non Current Liabilities	542M	419M	527M	467M	508M
Total Liabilities	11.93B	17.08B	19.63B	17.22B	15.8B
Common Stock, Total	90.52M	90.52M	90.52M	90.52M	91M
Additional Paid In Capital	330M	327M	306M	265M	194M
Retained Earnings	14.92B	15.66B	17.04B	19.1B	21.78B
Treasury Stock	-5.37B	-5.69B	-5.82B	-5.95B	-7.5B
Comprehensive Income and Other	-1.57B	-1.54B	-1.29B	-1.44B	-883M
Total Common Equity	8.4B	8.85B	10.33B	12.07B	13.68B
Minority Interest	15.36M	11.91M	11.39M	8.92M	9M
Total Equity	8.41B	8.86B	10.34B	12.08B	13.69B
Total Liabilities And Equity	20.34B	25.94B	29.96B	29.3B	29.49B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	129M	128M	128M	129M	127M
ECS Total Common Shares Outstanding	129M	128M	128M	129M	127M
Book Value / Share	65.03	68.88	80.41	93.87	108.07
Tangible Book Value	-3.18B	-2.03B	-8.75B	-6.25B	-4.39B
Tangible Book Value Per Share	-24.63	-15.79	-68.15	-48.61	-34.64
Total Debt	6.72B	11.62B	12.9B	10.79B	9.49B
Net Debt	5.95B	11.05B	12.42B	10.37B	9.02B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.02B	597M	380M	174M	-146M
Debt Equivalent Oper. Leases	493M	471M	590M	658M	664M
Minority Interest, Total (Incl. Fin. Div)	15.36M	11.91M	11.39M	8.92M	9M
Equity Method Investments, Total	292M	314M	297M	294M	280M
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	-	-	-	-	-
Inventories - Raw Materials, Total	267M	274M	625M	588M	576M
Inventories - Work In Process, Total	1.09B	1.13B	1.49B	1.42B	1.48B
Inventories - Finished Goods, Total	734M	812M	794M	778M	778M
Land - (BS)	343M	322M	385M	379M	411M
Buildings, Total	1.85B	1.78B	2.05B	2.02B	2.24B
Machinery, Total	3.65B	3.59B	4.09B	4.21B	4.43B
Full Time Employees	54.64K	55.09K	62.73K	61.12K	57.95K
Accumulated Allowance for Doubtful Accounts (Supple)	12.08M	9.94M	32.45M	21M	10M
Order Backlog	6.5B	7.85B	10.99B	10.86B	11.04B

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	1.75B	1.32B	2.08B	2.84B	3.53B
Depreciation & Amortization - CF	270M	257M	317M	349M	354M
Amortization of Goodwill and Intangible Assets - (CF)	325M	314M	501M	578M	553M
Depreciation & Amortization, Total	595M	572M	818M	927M	907M
(Gain) Loss From Sale Of Asset	-109M	-7.12M	-363M	-11.6M	-273M
(Gain) Loss on Sale of Investments - (CF)	-24.19M	1.16M	-6.18M	-5.71M	-
Stock-Based Compensation (CF)	121M	137M	143M	155M	159M
Other Operating Activities, Total	-47.26M	-320M	164M	20.1M	-243M
Change In Accounts Receivable	-299M	-179M	-16.68M	-85.09M	6M
Change In Inventories	-85.6M	-212M	53.12M	101M	-94M
Change In Accounts Payable	527M	131M	91.55M	-44.43M	119M
Change In Income Taxes	36.55M	32.51M	102M	26.6M	-18M
Change in Other Net Operating Assets	114M	971M	-89.26M	-543M	-318M
Cash from Operations	2.58B	2.44B	2.98B	3.38B	3.78B
Capital Expenditure	-210M	-230M	-381M	-400M	-435M
Sale of Property, Plant, and Equipment	141M	39.35M	13.24M	9.06M	32M
Cash Acquisitions	-	-	-7.15B	-	-
Divestitures	-	3.37M	473M	77.67M	623M
Investment in Marketable and Equity Securities, Total	44.61M	3.91M	19M	7.11M	-
Other Investing Activities, Total	24.74M	-235M	-1.16B	7.69M	4M
Cash from Investing	-13K	-419M	-8.18B	-299M	224M
Short Term Debt Issued, Total	-	1.42B	358M	359M	-
Long-Term Debt Issued, Total	1.21M	3.6B	2.02B	24.01M	751M
Total Debt Issued	1.21M	5.02B	2.38B	383M	751M
Short Term Debt Repaid, Total	-723M	-	-	-	-364M
Long-Term Debt Repaid, Total	-1.21B	-18.74M	-2.34B	-2.38B	-1.74B
Total Debt Repaid	-1.94B	-18.74M	-2.34B	-2.38B	-2.1B
Issuance of Common Stock	4.68M	2.83M	3.48M	3.61M	4M
Repurchase of Common Stock	-219M	-460M	-297M	-332M	-1.77B
Common Dividends Paid	-475M	-569M	-703M	-781M	-861M
Common & Preferred Stock Dividends Paid	-475M	-569M	-703M	-781M	-861M
Other Financing Activities, Total	-664K	-59.19M	-14.42M	-3.81M	-
Cash from Financing	-2.62B	3.92B	-971M	-3.11B	-3.98B
Foreign Exchange Rate Adjustments	95.95M	-23.77M	-4.78M	-24M	22M
Net Change in Cash	47.6M	5.91B	-6.17B	-53.16M	45M
Supplemental Items
Cash Interest Paid	237M	240M	465M	491M	384M
Cash Income Tax Paid (Refund)	486M	549M	411M	852M	927M
Levered Free Cash Flow	2.1B	-3.37B	7.46B	2.88B	3.02B
Unlevered Free Cash Flow	2.25B	-3.21B	7.82B	3.2B	3.28B
Change In Net Working Capital	-192M	5.59B	-4.95B	83.14M	-19M
Net Debt Issued / Repaid	-1.93B	5B	40.47M	-2B	-1.35B

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.39	7.85	7.8	8.38	8.95
Return on Total Capital	9.92	10.2	9.98	10.8	11.42
Return On Equity %	23.84	15.24	21.71	25.38	27.41
Return on Common Equity	23.88	15.26	21.73	25.4	27.42
Margin Analysis
Gross Profit Margin %	27.41	28.27	34.45	35.94	37.01
SG&A Margin	10.83	9.94	16.15	15.99	15.8
EBITDA Margin %	20.74	21.93	22.6	24.6	25.77
EBITA Margin %	18.85	20.3	20.93	22.84	23.99
EBIT Margin %	16.59	18.32	18.31	19.94	21.2
Income From Continuing Operations Margin %	12.18	8.3	10.93	14.27	17.79
Net Income Margin %	12.17	8.29	10.93	14.27	17.79
Net Avail. For Common Margin %	12.17	8.29	10.93	14.27	17.79
Normalized Net Income Margin	9.56	10.81	10.01	11.51	12.4
Levered Free Cash Flow Margin	14.61	-21.25	39.13	14.47	15.24
Unlevered Free Cash Flow Margin	15.7	-20.24	41.01	16.06	16.53
Asset Turnover
Asset Turnover	0.71	0.69	0.68	0.67	0.68
Fixed Assets Turnover	5.94	6.82	7.12	6.43	6.37
Receivables Turnover (Average Receivables)	6.99	6.91	7.17	6.7	6.55
Inventory Turnover (Average Inventory)	5.14	5.29	4.88	4.48	4.45
Short Term Liquidity
Current Ratio	1.81	2.06	0.88	0.93	1.19
Quick Ratio	1.02	0.53	0.47	0.5	0.65
Operating Cash Flow to Current Liabilities	0.83	0.42	0.39	0.46	0.65
Days Sales Outstanding (Average Receivables)	52.19	52.79	50.94	54.67	55.73
Days Outstanding Inventory (Average Inventory)	71.05	69.05	74.81	81.62	82.11
Average Days Payable Outstanding	48.12	53.94	52.34	58.5	59.85
Cash Conversion Cycle (Average Days)	75.12	67.9	73.4	77.79	77.99
Long Term Solvency
Total Debt/Equity	79.86	131.11	124.8	89.35	69.29
Total Debt / Total Capital	44.4	56.73	55.52	47.19	40.93
LT Debt/Equity	79.35	111.24	87.87	60.73	55.86
Long-Term Debt / Total Capital	44.12	48.13	39.09	32.07	33
Total Liabilities / Total Assets	58.64	65.85	65.5	58.77	53.58
EBIT / Interest Expense	9.52	11.39	6.08	7.85	10.29
EBITDA / Interest Expense	12.15	13.86	7.64	9.84	12.71
(EBITDA - Capex) / Interest Expense	11.31	12.96	6.97	9.05	11.65
Total Debt / EBITDA	2.21	3.28	2.94	2.17	1.82
Net Debt / EBITDA	1.96	3.13	2.83	2.08	1.73
Total Debt / (EBITDA - Capex)	2.38	3.51	3.22	2.35	1.99
Net Debt / (EBITDA - Capex)	2.1	3.34	3.1	2.26	1.89
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.76	10.55	20.2	4.53	-0.4
Gross Profit, 1 Yr. Growth %	11.34	13.99	23.55	9.04	2.57
EBITDA, 1 Yr. Growth %	17.99	16.91	25.31	13.77	3.56
EBITA, 1 Yr. Growth %	19.25	19.06	25.47	14.07	3.72
EBIT, 1 Yr. Growth %	19.95	22.13	21.77	13.88	4.88
Earnings From Cont. Operations, 1 Yr. Growth %	45.29	-24.65	58.3	36.54	24.15
Net Income, 1 Yr. Growth %	45.27	-24.65	58.33	36.55	24.16
Normalized Net Income, 1 Yr. Growth %	22.51	25.05	11.3	20.19	6.2
Diluted EPS Before Extra, 1 Yr. Growth %	44.17	-24.42	58.97	36.16	24.18
Accounts Receivable, 1 Yr. Growth %	17.64	6.87	24.51	1.74	1.86
Inventory, 1 Yr. Growth %	6.44	5.93	31.31	-4.16	1.87
Net Property, Plant and Equip., 1 Yr. Growth %	-1.36	-5.93	37.3	0.12	0.87
Total Assets, 1 Yr. Growth %	2.28	27.54	15.5	-2.22	0.67
Tangible Book Value, 1 Yr. Growth %	-41.54	-36.25	331.6	-28.57	-29.84
Common Equity, 1 Yr. Growth %	34.86	5.35	16.71	16.9	13.34
Cash From Operations, 1 Yr. Growth %	24.34	-5.18	22.04	13.57	11.58
Capital Expenditures, 1 Yr. Growth %	-9.73	9.57	65.51	5.09	8.75
Levered Free Cash Flow, 1 Yr. Growth %	62.77	-260.78	-319.62	-61.32	8.37
Unlevered Free Cash Flow, 1 Yr. Growth %	52.15	-242.54	-341.52	-59.04	5.57
Dividend Per Share, 1 Yr. Growth %	4.26	20.44	23.76	10.97	10.21
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.1	7.62	15.27	12.09	2.04
Gross Profit, 2 Yr. CAGR %	3.86	13.8	17.34	16.07	6.76
EBITDA, 2 Yr. CAGR %	8.8	19.6	20.56	20.18	10.41
EBITA, 2 Yr. CAGR %	8.74	21.59	21.7	20.48	10.78
EBIT, 2 Yr. CAGR %	7.03	23.87	21.38	18.68	11.61
Earnings From Cont. Operations, 2 Yr. CAGR %	7.02	4.63	9.21	47.02	30.19
Net Income, 2 Yr. CAGR %	7.02	4.62	9.22	47.03	30.2
Normalized Net Income, 2 Yr. CAGR %	5.13	27.07	17.97	50.49	15.69
Diluted EPS Before Extra, 2 Yr. CAGR %	7.42	4.39	9.61	47.12	30.03
Accounts Receivable, 2 Yr. CAGR %	1.48	12.12	15.35	12.55	1.81
Inventory, 2 Yr. CAGR %	11.62	6.18	17.94	12.18	-1.19
Net Property, Plant and Equip., 2 Yr. CAGR %	16.46	-3.67	13.65	17.25	0.5
Total Assets, 2 Yr. CAGR %	7.58	14.22	21.37	6.27	-0.79
Tangible Book Value, 2 Yr. CAGR %	57.95	-38.95	65.87	75.58	-29.21
Common Equity, 2 Yr. CAGR %	18.69	19.2	10.89	16.81	15.1
Cash From Operations, 2 Yr. CAGR %	22	8.58	7.58	17.73	12.57
Capital Expenditures, 2 Yr. CAGR %	3.74	-0.55	34.66	31.88	6.85
Levered Free Cash Flow, 2 Yr. CAGR %	17.04	65.42	88.95	-8.23	-35.55
Unlevered Free Cash Flow, 2 Yr. CAGR %	16.87	50.14	86.59	-0.99	-34.47
Dividend Per Share, 2 Yr. CAGR %	7.77	12.06	22.08	17.19	10.59
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.11	3.47	11.66	11.58	7.76
Gross Profit, 3 Yr. CAGR %	2.9	7.13	23.8	14.5	11.38
EBITDA, 3 Yr. CAGR %	6.94	11.43	21.01	18.25	14.66
EBITA, 3 Yr. CAGR %	7.22	12.08	22.36	19.11	14.93
EBIT, 3 Yr. CAGR %	6.56	11.84	22.6	18.83	14.25
Earnings From Cont. Operations, 3 Yr. CAGR %	18.07	-4.79	20.11	17.65	38.96
Net Income, 3 Yr. CAGR %	18.07	-4.79	20.11	17.66	38.97
Normalized Net Income, 3 Yr. CAGR %	7.25	11.39	21.58	18.7	34.44
Diluted EPS Before Extra, 3 Yr. CAGR %	19.46	-4.46	20.1	17.83	39.04
Accounts Receivable, 3 Yr. CAGR %	1.11	3.24	16.11	10.62	8.88
Inventory, 3 Yr. CAGR %	8.84	9.69	13.97	10.05	8.63
Net Property, Plant and Equip., 3 Yr. CAGR %	8.92	8.46	8.41	8.95	11.52
Total Assets, 3 Yr. CAGR %	9.91	13.86	14.64	12.93	4.37
Tangible Book Value, 3 Yr. CAGR %	24.21	16.73	17.17	25.26	29.32
Common Equity, 3 Yr. CAGR %	12.75	14.06	18.37	12.86	15.64
Cash From Operations, 3 Yr. CAGR %	17.27	12.17	12.9	9.54	15.64
Capital Expenditures, 3 Yr. CAGR %	-5.36	5.65	17.85	23.98	23.66
Levered Free Cash Flow, 3 Yr. CAGR %	17.41	30.11	82.28	11.34	-4.05
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.39	24.87	76.41	12.54	0.16
Dividend Per Share, 3 Yr. CAGR %	10.23	11.84	15.83	18.26	14.82
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.78	5.69	5.92	6.83	7.71
Gross Profit, 5 Yr. CAGR %	8.52	8.76	12.72	14.46	16.24
EBITDA, 5 Yr. CAGR %	13.46	14.12	12.11	14.29	16.04
EBITA, 5 Yr. CAGR %	14.21	15.11	12.7	14.75	16.93
EBIT, 5 Yr. CAGR %	13.29	15.05	12.16	13.86	17.32
Earnings From Cont. Operations, 5 Yr. CAGR %	16.7	5.99	14.44	13.28	24.05
Net Income, 5 Yr. CAGR %	16.7	5.99	14.45	13.28	24.05
Normalized Net Income, 5 Yr. CAGR %	12.82	15.41	11.42	13.08	18.3
Diluted EPS Before Extra, 5 Yr. CAGR %	17.78	6.83	15.42	13.55	23.98
Accounts Receivable, 5 Yr. CAGR %	6.83	4.19	6.58	6.87	10.16
Inventory, 5 Yr. CAGR %	12.25	7.4	12.39	10.68	7.65
Net Property, Plant and Equip., 5 Yr. CAGR %	8.87	3.09	10.79	11.89	5.17
Total Assets, 5 Yr. CAGR %	11.07	10.87	14.36	10.76	8.2
Tangible Book Value, 5 Yr. CAGR %	33.52	-5.09	39.44	37.43	-4.22
Common Equity, 5 Yr. CAGR %	12.92	10.95	12	15.15	17.05
Cash From Operations, 5 Yr. CAGR %	16.29	13.43	13.29	14.36	12.76
Capital Expenditures, 5 Yr. CAGR %	7.04	2.46	8.98	15.45	13.34
Levered Free Cash Flow, 5 Yr. CAGR %	10.01	36.14	41.94	13.52	19.69
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.19	31.32	40.49	14.18	18.16
Dividend Per Share, 5 Yr. CAGR %	7.81	11.37	14.83	13.95	13.7